777 related articles for article (PubMed ID: 31601232)
1. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
[TBL] [Abstract][Full Text] [Related]
2. Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.
Chatterjee P; Goozee K; Sohrabi HR; Shen K; Shah T; Asih PR; Dave P; ManYan C; Taddei K; Chung R; Zetterberg H; Blennow K; Martins RN
J Alzheimers Dis; 2018; 63(2):479-487. PubMed ID: 29630554
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults.
Chatterjee P; Cheong YJ; Bhatnagar A; Goozee K; Wu Y; McKay M; Martins IJ; Lim WLF; Pedrini S; Tegg M; Villemagne VL; Asih PR; Dave P; Shah TM; Dias CB; Fuller SJ; Hillebrandt H; Gupta S; Hone E; Taddei K; Zetterberg H; Blennow K; Sohrabi HR; Martins RN
J Neurochem; 2021 Oct; 159(2):389-402. PubMed ID: 32679614
[TBL] [Abstract][Full Text] [Related]
4. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
5. Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.
Chatterjee P; Goozee K; Lim CK; James I; Shen K; Jacobs KR; Sohrabi HR; Shah T; Asih PR; Dave P; ManYan C; Taddei K; Lovejoy DB; Chung R; Guillemin GJ; Martins RN
Sci Rep; 2018 May; 8(1):8008. PubMed ID: 29789640
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study.
Parker DC; Kraus WE; Whitson HE; Kraus VB; Smith PJ; Cohen HJ; Pieper CF; Faldowski RA; Hall KS; Huebner JL; Ilkayeva OR; Bain JR; Newby LK; Huffman KM
J Alzheimers Dis; 2023; 91(3):1141-1150. PubMed ID: 36565121
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
[TBL] [Abstract][Full Text] [Related]
9. Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition.
Rauchmann BS; Schneider-Axmann T; Perneczky R;
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1289-1295. PubMed ID: 34187867
[TBL] [Abstract][Full Text] [Related]
10. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.
Lewczuk P; Ermann N; Andreasson U; Schultheis C; Podhorna J; Spitzer P; Maler JM; Kornhuber J; Blennow K; Zetterberg H
Alzheimers Res Ther; 2018 Jul; 10(1):71. PubMed ID: 30055655
[TBL] [Abstract][Full Text] [Related]
11. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
[TBL] [Abstract][Full Text] [Related]
12. Correlations between kynurenines in plasma and CSF, and their relation to markers of Alzheimer's disease pathology.
Bakker L; Köhler S; Eussen SJPM; Choe K; van den Hove DLA; Kenis G; Rutten BPF; Ulvik A; Ueland PM; Verhey FRJ; Ramakers IHGB
Brain Behav Immun; 2023 Jul; 111():312-319. PubMed ID: 37149106
[TBL] [Abstract][Full Text] [Related]
13. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
[TBL] [Abstract][Full Text] [Related]
14. Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau.
Jacobs KR; Lim CK; Blennow K; Zetterberg H; Chatterjee P; Martins RN; Brew BJ; Guillemin GJ; Lovejoy DB
Neurobiol Aging; 2019 Aug; 80():11-20. PubMed ID: 31055163
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease.
Liang Y; Xie S; He Y; Xu M; Qiao X; Zhu Y; Wu W
Dis Markers; 2022; 2022():9484217. PubMed ID: 35096208
[TBL] [Abstract][Full Text] [Related]
16. Effect of Long-Term Storage on the Reliability of Blood Biomarkers for Alzheimer's Disease and Neurodegeneration.
Schubert CR; Paulsen AJ; Pinto AA; Merten N; Cruickshanks KJ
J Alzheimers Dis; 2022; 85(3):1021-1029. PubMed ID: 34924380
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis.
Rajda C; Galla Z; Polyák H; Maróti Z; Babarczy K; Pukoli D; Vécsei L
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290514
[TBL] [Abstract][Full Text] [Related]
18. Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
Koychev I; Jansen K; Dette A; Shi L; Holling H
J Alzheimers Dis; 2021; 79(1):177-195. PubMed ID: 33252080
[TBL] [Abstract][Full Text] [Related]
19. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults.
Hu H; Chen KL; Ou YN; Cao XP; Chen SD; Cui M; Dong Q; Tan L; Yu JT;
Aging (Albany NY); 2019 Sep; 11(17):6904-6914. PubMed ID: 31514172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
